Bright Minds Biosciences Inc.Bright Minds Biosciences Inc.Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.48 M‬USD
−1.0029USD
‪−5.43 M‬USD
‪2.88 M‬
Beta (1Y)
−1.37

About BRIGHT MINDS BIOSCIENCES INC.

CEO
Ian B. McDonald
Headquarters
New York
Founded
2019
FIGI
BBG00ZKX9FP7
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DRUG is 0.9625 USD — it has increased by 0.25% in the past 24 hours. Watch Bright Minds Biosciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bright Minds Biosciences Inc. stocks are traded under the ticker DRUG.
DRUG stock has fallen by 11.70% compared to the previous week, the month change is a 5.80% fall, over the last year Bright Minds Biosciences Inc. has showed a 61.50% decrease.
DRUG reached its all-time high on Nov 8, 2021 with the price of 44.7500 USD, and its all-time low was 0.9300 USD and was reached on Apr 30, 2024. View more price dynamics on DRUG chart.
See other stocks reaching their highest and lowest prices.
DRUG stock is 7.27% volatile and has beta coefficient of −1.37. Track Bright Minds Biosciences Inc. stock price on the chart and check out the list of the most volatile stocks — is Bright Minds Biosciences Inc. there?
Today Bright Minds Biosciences Inc. has the market capitalization of ‪4.48 M‬, it has decreased by 0.53% over the last week.
Yes, you can track Bright Minds Biosciences Inc. financials in yearly and quarterly reports right on TradingView.
Bright Minds Biosciences Inc. is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
DRUG net income for the last quarter is ‪−423.83 K‬ USD, while the quarter before that showed ‪−1.27 M‬ USD of net income which accounts for 66.65% change. Track more Bright Minds Biosciences Inc. financial stats to get the full picture.
No, DRUG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 15, 2024, the company has 0 employees. See our rating of the largest employees — is Bright Minds Biosciences Inc. on this list?
Like other stocks, DRUG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bright Minds Biosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bright Minds Biosciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bright Minds Biosciences Inc. stock shows the sell signal. See more of Bright Minds Biosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.